New study examines Igalmi's effects after repeated use for agitation
NCT ID NCT06041646
First seen Jan 04, 2026 · Last updated May 16, 2026 · Updated 26 times
Summary
This study looked at what happens when people with schizophrenia or bipolar disorder take Igalmi repeatedly for agitation over 7 days, and then stop. Researchers wanted to see if the drug becomes less effective (tolerance) or causes withdrawal symptoms. 29 adults participated in this in-clinic study, and the results help understand how the drug works with repeated use.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BioXcel Clinical Research Site
Little Rock, Arkansas, 72211, United States
-
BioXcel Clinical Research Site
Rogers, Arkansas, 72758, United States
Conditions
Explore the condition pages connected to this study.